The opportunity is not in buying every low-priced penny stock but rather in finding smaller companies where earnings, balance ...

Altitude Lab, the platform-first biotech-startup accelerator founded by Recursion (NASDAQ: RXRX), announced today that its portfolio companies have collectively raised more ...

Big Pharma is pouring money into tech-devised treatments, but the verdict is out on whether they’ll actually work.

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

UIUC and Stanford's RecursiveMAS lets AI agents collaborate in embedding space instead of text, cutting token usage by 75% ...

Detailed price information for Caris Life Sciences Inc (CAI-Q) from The Globe and Mail including charting and trades.

A new frontier AI company called Recursive Superintelligence has emerged from stealth with $650 million in funding and an ...

With a stock price of $3.32, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the 10 Unrivaled Penny Stocks to Buy Now.

The average one-year price target for Recursion Pharmaceuticals (NasdaqGS:RXRX) has been revised to $6.12 / share. This is a ...

Isomorphic Labs secures $2.1 billion to advance AI-designed drug development, partnering with major pharmaceutical companies ...

"Anti-AI" stocks are a contrarian bet that the market's tech-fueled rally will be short-lived. It may be time for an anti-AI portfolio. That's because AI-related stocks have been soaring. "Anti-AI" ...

Recursion Pharmaceuticals (RXRX) has been in focus after fresh clinical updates on REC-4881 and REC-1245, along with ongoing FDA discussions for a potential registrational pathway, drew attention away ...